Unlock instant, AI-driven research and patent intelligence for your innovation.

Method and composition for treatment of cancer

A composition and compound technology, applied in the direction of drug combination, pharmaceutical formulation, drug delivery, etc.

Inactive Publication Date: 2004-12-01
UNISEARCH LTD
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Nevertheless, its use comes with certain disadvantages and side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method and composition for treatment of cancer
  • Method and composition for treatment of cancer
  • Method and composition for treatment of cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0093] In vitro test against liver cancer cells

[0094] Method: use 3 [H]thymidine incorporation assay to investigate the effect of clofazimine on cell proliferation. Adherent cells (5 / 000-10 / 000) were plated into 24-well Corning tissue culture dishes and exposed to clofazimine containing vehicle or different concentrations (10 -9 -10 -5 mol / L) medium (MEM 5% FBS). For Novikoff, which is a detached rat cell line, 2000 cells were suspended in 2 ml DMEM (5% FBS) and maintained under the same conditions as for adherent cells. The medium was replaced with fresh medium every other day. At the end of the treatment period (5-10 days), by adding 0.5 μCi to each well [ 3 H] thymidine and a final incubation of 4 hours to measure thymidine incorporation into the cell culture. The amount of incorporated radioactivity was determined using a β-scintillation counter (18). Results are expressed as actual counts per minute - drug concentration used in medium or % inhibition (reduction ...

Embodiment 2

[0100] In vitro test of anti-HepG2 cells

[0101] HepG2 cells plated in 6-well plates were treated with clofazimine (0-5 μM) for 1, 3 or 7 days, and the remaining viable cells were counted using the trypan blue dye method. All counts were obtained in quadruplicate. The results are attached figure 2 , where the values ​​represent the mean ± standard error.

Embodiment 3

[0103] In Vitro Test of Novikoff Against Rat Hepatoma Cells

[0104] Rat hepatoma cells novikoff were grown in test tubes and treated with different concentrations of clofazimine (0-10 μM) for 1, 3 or 7 days. At the end of the treatment period, the number of remaining viable cells was counted using the trypan blue method. All counts were obtained in triplicate and values ​​represent mean ± standard error. The results are attached image 3 shown.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a method of treatment of tumours. The method comprises regional delivery to the site of the tumour a composition comprising a therapeutically effective amount of a riminophenazine compound. The present invention also provides composition comprising riminophenazine compounds in combination with lipids.

Description

field of invention [0001] The present invention relates to a method for treating cancer, especially a method for treating liver cancer. The invention also relates to compositions useful in such treatments. Background of the invention [0002] Hepatocellular carcinoma (HCC) is one of the most lethal malignancies and is the seventh most common cancer worldwide. Its incidence varies widely and occurs most frequently in Asian countries. Due to an insidious onset, most HCCs are unresectable at the time of diagnosis. Chemotherapeutic agents currently used systemically to treat HCC are not very successful (1-5). In recent years, the advantages of locally delivered drugs to treat HCC have been described. This route of administration achieves higher drug concentrations directly at the tumor site, sparing the rest of the body from toxic effects. In addition, drug delivery in oils such as lipiodol, which are highly uptaken by liver tumors and retained for a long time, can further ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/00A61K31/498A61K47/14C07D241/46A61K47/44A61P35/00A61P35/04
CPCA61K9/0019A61K47/44A61K47/14A61K31/498A61P35/00A61P35/04
Inventor D·L·莫里斯M·H·波格霍拉米
Owner UNISEARCH LTD